VRC
Home
Clinical Studies
How to Volunteer
CURRENT CLINICAL TRIALS
We are currently enrolling volunteers. If you are interested
in volunteering to participate in a clinical trial, please
call us at 1-866-833-LIFE (5433) or or e-mail
us at VRCforlife@mail.nih.gov.
The Clinical Trials listed below link to www.clinicaltrials.gov.
By clicking on the links below, you will leave the VRC web
site. To return to the VRC web site, click on the back button in your bowser.
VRC
Clinical Trials Related to Development of an HIV Vaccine
HIV
Vaccine Studies
VRC 000 (02-I-0127):
Screening
Subjects for HIV Vaccine Research Studies
VRC 004 (03-I-0022):
A
Phase I Clinical Trial to Evaluate the Safety and Immunogenicity
of a Multiclade HIV-1 DNA Plasmid Vaccine, VRC-HIVDNA009-00-VP,
in Uninfected Adult Volunteers
VRC 006 (04-I-0172):
A
Phase I Clinical Trial to Evaluate the Safety and Immunogenicity
of a Recombinant Multiclade HIV-1 Adenoviral Vector
Vaccine, VRC-HIVADV014-00-VP, in Uninfected Adult Volunteers
VRC 007 (04-I-0254):
A Phase I Clinical Trial to
Evaluate the Safety and Immunogenicity of a 6-Plasmid Multiclade HIV-1 DNA Vaccine, VRC-HIVDNA016-00-VP,
in Uninfected Adult Volunteers
VRC 100 (03-I-0079):
Screening
HIV-Infected Subjects for Vaccine Research Studies
|
VRC
Clinical Trials Related to Biodefense
VRC 300 (03-I-0285):
Screening
of Healthy Volunteers for Clinical Trials of Investigational
Vaccines to Prevent Infectious Diseases
Ebola Vaccine Studies
VRC 204 (04-I-0028):
A
Phase I Clinical Trial to Evaluate the Safety and Immunogenicity
of a Multiple Strain Ebola DNA Plasmid Vaccine, VRC-EBODNA012-00-VP,
in Adult Volunteers
Smallpox
Vaccine Studies
VRC 201 (02-I-0316):
A
Phase I/II Clinical Trial of Modified Vaccinia Virus
Ankara (MVA) to Evaluate its Safety, Dosing Schedule,
Immunogenicity and Protective Efficacy Against Dryvax
Challenge in Vaccinia-Naive Individuals
VRC 203 (03-I-0087):
A
Phase I/II Clinical Trial of Modified Vaccinia Virus
Ankara (MVA) to Evaluate its Safety, Immunogenicity
and Protective Efficacy Against Dryvax Challenge in
Vaccinia-Immune Individuals
|
| VRC
Protocols to Obtain Laboratory Samples for Vaccine and
Immunology Research VRC PAN (02-I-0066):
Studies
of Specific Immune Responses in Human Peripheral Blood
Cells in HIV-Infected and HIV-Uninfected Volunteers
VRC 200 (03-I-0263):
Apheresis
Procedures to Obtain Plasma or Peripheral Blood Mononuclear
Cells (PBMCs) for Research Studies
|
|
